We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Chemical Can Induce Nerve Growth after Stroke

By Biotechdaily staff writers
Posted on 09 Jul 2002
An animal study has shown that inosine, a naturally occurring chemical, can induce axon growth within the brain and spinal cord, thereby improving motor function after a stroke.
The study was published in the June 25, 2002, issue of the Proceedings of the National Academy of Sciences.

In the study, rats treated with inosine had nearly normal paw-placing ability after 19 days, whereas untreated rats remained 50% below normal. The results of anatomical studies correlated with functional results. Inosine showed the ability to increase the capacity of nerve cells to make new connections to those brain areas that had lost their normal inputs because of a stroke. The inosine-stimulated increases were three to four times higher than in the rats not receiving inosine. There were no apparent side effects.

"The study shows that inosine induces a great deal of rewiring in the brain after stroke,” said Dr. Larry Denowitz, principal investigator and head of the laboratory at Children's Hospital (Boston, MA, USA), where much of the study was conducted. "This rewiring is apparently sufficient to promote substantial functional recovery.”

Inosine is being developed for the treatment of stroke and other central nervous system injuries by Boston Life Sciences, Inc. (BLSI, MA, USA). "Stroke has been a poorly understood and inadequately treated area of medicine,” said Dr. Marc Lanser, M.D., chief scientific officer of BLSI. "These data offer great hope that we may finally see a breakthrough in treatment that can repair the damage by stroke.”






Related Links:
Chidlren's Hosp.
BLSI

New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Hematology Consumables
Bioblood Devices
New
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5

Latest BioResearch News

Study Identifies Protein Changes Driving Immunotherapy Resistance in Multiple Myeloma
09 Jul 2002  |   BioResearch

Genetic Analysis Identifies BRCA-Linked Risks Across Multiple Cancers
09 Jul 2002  |   BioResearch

Study Identifies Hidden B-Cell Mutations in Autoimmune Disease
09 Jul 2002  |   BioResearch